Fig. 3From: Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort studyIPTW-weighted cumulative probability curves in patients treated with pirfenidone or nintedanib. a comparison of risk for all-cause hospitalization, b comparison of risk for respiratory-related hospitalization. The colored areas represent 95% confidence intervalsBack to article page